Daiichi Sankyo Co Ltd - Company & Market Research Reports

Home /
Companies /
Daiichi Sankyo Co Ltd

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 128
Cardiovascular Drugs 98
Drug Discovery 77
Vaccines 49
Central Nervous System Drugs 46
Endocrine and Metabolic Disorders Drugs 39
Pharmaceuticals 35
Hematological Drugs 35
Infectious Diseases Drugs 34
Clinical Trials 33
Immune Disorders Drugs 31
Musculoskeletal Disorders Drugs 31
Leukemia Drugs 28
Genomics 28
Analgesics 24
Biopharmaceuticals 24
Skin Cancer Drugs 18
Diabetes Drugs 17
Contrast Media 17
Infusions and Injectables 16
Liver and Kidney Disorders Drugs 16
Oncology 16
Biotechnology 15
Lung Cancer Drugs 15
Antibiotics 15
Women's Health 14
Gastrointestinal Drugs 13
Breast Cancer Drugs 12
Brain Cancer Drugs 12
Allergy and Immunology 11
Enzymes 11
Diagnostics 11
Hematology 10
Biosimilars and Biosuperiors 10
Alzheimer's Disease Drugs 10
Pharmaceutical Manufacturing 10
Respiratory Drugs 9
Cardiology 8
Healthcare Services 7
Colon Cancer Drugs 7
Urological Disorders Drugs 7
Animal Pharmaceuticals 6
Liver Cancer Drugs 6
Lymphoma Drugs 6
Infectious Disease Testing 6
Managed Care 6
Optical Disorders Drugs 5
Pulmonary Medicine 5
Neurology 5
Ovarian Cancer Drugs 5
Stem Cells 5
Thyroid Cancer Drugs 5
Dermatological Drugs 5
Pharmaceutical Intermediates 4
Therapeutic Area 4
Cervical Cancer Drugs 4
In Vitro Diagnostics 4
Ultrasound 4
Transdermal and Transmucosal Drug Delivery 4
Drug Delivery 4
Pancreatic Cancer Drugs 4
Gastroenterology 4
Company Reports 3
Drugs by Therapeutic Area 3
Prostate Cancer Drugs 3
Medical Devices 3
Neurology Devices 3
Anti-Obesity Drugs 3
HIV/AIDS Drugs 3
Addiction Disorders Drugs 2
Urology and Nephrology 2
Generic Drugs 2
Bladder Cancer Drugs 2
Proteomics 2
Cardiovascular Devices 2
Blood Banking 2
Anesthetic Drugs 2
Needles and Syringes 2
Over the Counter (OTC) Drugs 2
Nuclear Medicine and Radiopharmacology 2
Cancer Vaccines 2
Laboratory Equipment 2
Palliative Care 2
Pediatrics 2
Acne Drugs 2
Bronchitis Drugs 2
Schizophrenia Drugs 2
Psoriasis Drugs 2
Patient Monitoring Equipment 1
Pharmacoeconomics 1
Medical Imaging 1
Hospital Information Systems 1
Coagulation and Hemostasis Testing 1
Healthcare 1
Dental 1
Magnetic Resonance Imaging (MRI) 1
Radiography 1
Diabetes Devices 1
Optical 1
Hospital Management 1
Biomarkers 1
Dermatology 1
Surgical Procedures 1
Molecular Diagnostics 1
Catheters 1
Mental Disorders Drugs 1
Uterine Cancer Drugs 1
Vitamins and Dietary Supplements 1
Other Healthcare Facilities 1
Nanomedicine 1
Endocrinology 1
Asthma Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



273 reviews

863 Results (Page 22 of 44)
- Relevance
  Sort by

Intratumoral Cancer Therapies Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Myeloproliferative Disorders Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Germ Cell Tumor Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Intestine Cancer Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Nasopharyngeal Carcinoma Treatment Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Sarcoma Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Antibody Drug Conjugates Market Report 2025

 Report
March 2025
250 Pages
Global

From

€3965EUR$4,490USD£3,387GBP

Fibrodysplasia Ossificans Progressiva Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,245USD£3,094GBP

Drug Manufacturing Sector Scorecard - Thematic Intelligence

 Report
October 2022
23 Pages
Global

From

€1722EUR$1,950USD£1,471GBP

Dyslipidemia Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4388EUR$4,969USD£3,748GBP

Antibody-drug Conjugates - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
200 Pages
Global

From

€4195EUR$4,750USD£3,583GBP

DNA Topoisomerase I Inhibitors - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1766EUR$2,000USD£1,509GBP

Anticoagulants Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€3974EUR$4,500USD£3,394GBP

Vasculitis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 To 2030

 Report
August 2022
119 Pages
Global

From

€3974EUR$4,500USD£3,394GBP

Macrophage Colony Stimulating Factor Receptor Antagonists - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1766EUR$2,000USD£1,509GBP

BET Inhibitor - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1766EUR$2,000USD£1,509GBP

Akt1 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
120 Pages
Global

From

€1766EUR$2,000USD£1,509GBP

Gastrointestinal Stromal Tumors - Pipeline Insight, 2025

 Clinical Trials
April 2025
85 Pages
Global

From

€1766EUR$2,000USD£1,509GBP

Soft Tissue Sarcoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
280 Pages
Global

From

€2650EUR$3,000USD£2,263GBP

Antibody Drug Conjugate - Competitive Landscape, 2025

 Report
March 2025
450 Pages
Global

From

€4416EUR$5,000USD£3,772GBP

863 Results (Page 22 of 44)
- 1
- 20
- 21
- 22
- 23
- 24

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.